Combined antiretroviral and antituberculosis drug resistance following incarceration. S Afr J HIV Med, 14(3): 135-137 (2013).

Publication Latest Publications

Title: Combined antiretroviral and antituberculosis drug resistance following incarceration
Authors: Stott KE, de Oliveira T, Lessells RJ.
Journal: S Afr J HIV Med,14(3):135-137 (2013)
Number of citations (Google Scholar): 3

Abstract

We describe a case of HIV/tuberculosis (TB) co-infection from KwaZulu-Natal, South Africa, characterised by drug resistance in both pathogens. The development of drug resistance was linked temporally to two periods of incarceration. This highlights the urgent need for improved integration of HIV/TB control strategies within prison health systems and within the broader public health framework.

Download: Full text paper

Citation: Stott KE, de Oliveira T, Lessells RJ. Combined antiretroviral and antituberculosis drug resistance following incarceration S Afr J HIV Med,14(3):135-137 (2013).


Impact of point-of-care Xpert MTB/RIF on tuberculosis treatment initiation: a cluster randomised trial
Journal: Am J Respir Crit Care Med (2017)

Hyperbilirubinemia in atazanavir-treated human immunodeficiency virus-infected patients: the impact of the UGT1A1*28 allele
Journal: Pharmacogenomics and Personalized Medicine (2017)

Rates of virological suppression and drug resistance in adult HIV-1-positive patients attending primary healthcare facilities in KwaZulu-Natal, South Africa
Journal: Journal of Antimicrobial Chemotherapy (2017)
All publications...


KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), K-RITH Tower Building, Nelson R Mandela School of Medicine, UKZN

Contact: Prof. Tulio de Oliveira, Tel: +27 31 260 4898, Email: tuliodna@gmail.com & deoliveira@ukzn.ac.za

Page design updated 2013. Many of the pages were previously hosted at bioafrica.net.